Open AccessOutcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study
Author(s) -
Hyo Sik Chang,
Pei-Yun Chou,
ChengJen Chou,
Hung-Chin Tsai
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s331647
Subject(s) - medicine , discontinuation , regimen , tolerability , viral load , viremia , rash , adverse effect , clinical endpoint , gastroenterology , human immunodeficiency virus (hiv) , immunology , clinical trial